Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplantation Results in Patients with Hurler Syndrome: Clinical Cases
Mucopolysaccharidosis type I (MPS I) is the hereditary disease characterized with alpha-L-iduronidase activity decrease and further accumulation of heparan and dermatan sulfate in lysosomes. MPS I is rare autosomal recessive disorder with incidence of 0.5-4 cases on 100.000 live-birth infants. Meant...
Saved in:
Main Authors: | Nato D. Vashakmadze (Author), Leyla S. Namazova-Baranova (Author), Natalia V. Zhurkova (Author), Ekaterina Yu. Zakharova (Author), Svetlana V. Mikhaylova (Author), Grigory V. Revunenkov (Author) |
---|---|
Format: | Book |
Published: |
"Paediatrician" Publishers LLC,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mucopolysaccharidosis type II: Enzyme Replacement Therapy Efficiency
by: Nato D. Vashakmadze, et al.
Published: (2020) -
Combination Treatment for Severe Forms of Mucopolysaccharidosis, Type I (Hurler Syndrome): Case Report
by: Nato V. Vashakmadze, et al.
Published: (2023) -
Results of 14-year-long Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II: Clinical Case
by: Natalia V. Zhurkova, et al.
Published: (2023) -
Hematopoietic stem cell transplant for Hurler's disease: A Case Report
by: Anamika Bakliwal, et al.
Published: (2016) -
Allergic Reactions at Enzyme Replacement Therapy in Children with Mucopolysaccharidosis Type II
by: Julia G. Levina, et al.
Published: (2021)